Hybrid Clinical Trials: Combining the Best of Both Worlds

Hybrid trials combine pragmatic and traditional clinical trial strategies to generate real-world data. Some clinical research happens remotely using wearables, mobile phones, apps, and other medical devices, while some happen physically. The medical center has to be fully equipped to handle a hybrid clinical trials without setbacks.

The patient recruitment rate is better with this clinical trial design. Traditional trials can sometimes be too demanding. But this mix of both allows the patient population to participate remotely but also get a chance to interact with the clinical staff personally.

The rise of virtual trials in the United States and worldwide is forcing medical centers to adjust. If a clinical practice can’t afford a virtual trial, they can opt for the hybrid model. It’s more affordable to implement and still guarantees accurate results. With the covid-19 pandemic, health professionals had to find a way to continue clinical studies without meeting patients; that’s how virtual visits started mainstreaming. For most trials, the hybrid model offers the most flexibility for researchers and patients.

Answering the Lack of Diversity in Clinical Trials

For a long time, there was a lack of diversity in the clinical trials conducted by most pharmaceutical companies. This can greatly impact the treatment effects after a drug hits the market. One way of handling the issue is by implementing virtual or hybrid trials. Remote studies can reach a more diverse patient population, allowing clinical practice to gather a wide range of data.

The second stage of the trial is what requires an in-person visit from the participants. Undergoing a study from home sounds more appealing to most patients. This increases the patient recruitment rate and reduces the number of dropouts.

The trial arms should include patients from different demographics. If a trial arm only studies one type of patient, the chances of the study generating accurate real-world data are low. Dr. Wang and many other professionals will tell you that virtual and hybrid clinical trials are the answer to the lack of diversity.

The hybrid model can conduct any type of study, including the mammary artery, a study of side sleepers, or even silico trials. The possibilities are endless, especially when it’s rightfully implemented. However, silicon trials require a wider range of technological strategies. The conditional outcome distributions should be better when you include a lot of sub-populations in your study. There are challenges with decentralized clinical trials, but there is so much good that can come from the studies.

Virtual Tools in Hybrid Clinical Trials

Hybrid trials won’t be possible without virtual tools. The purpose of such a trial is to demonstrate the efficacy and safety of new treatments compared to what is already available. The clinical trial design uses many tools to ensure the data represents real-world patients. An arsenal of digital tools should include health software. The software ensures seamless management of the trial and easy data assembly.

You should be able to collect data in real-time, which requires various electronic devices. You have to supply the patient with the right tools before commencing the trial. During patient recruitment, you might need to collect electronic signatures from participants. Ensure you have the virtual tools to make that possible. Social media and other marketing tools are crucial for reaching the right audience when trying to recruit.

You need patient portals where they can access video training and support. Email and phone support are necessary whenever you need direct communication with participants. The study would be difficult without clinical trial management tools for scheduling, data analytics, and other workflow issues.

You can do some research or find useful articles on PubMed or Google to discover the virtual risk management tools you will require. The telemedicine platform will be useful throughout the study. Success is strongly influenced by the quality of the tools you use. Be sure the clinical practice has everything it needs before the trial starts.

Crosstrek hybrid should be the only hybrid you keep your eyes on in the coming days. Hybrid clinical trials are taking over. It is easier to develop hybrid immunity with drugs derived from scientific studies. Clinical trials are flexible and very convenient for all the involved parties. It’s the right blend of both worlds. Virtual trials are helpful, but a hybrid model is ideal when you want to include some traditional strategies in the study.